110 related articles for article (PubMed ID: 20111903)
21. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
Tang C; Chen N; Wu M; Yuan H; Du Y
Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
[TBL] [Abstract][Full Text] [Related]
22. XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
Romanowicz-Makowska H; Sobczuk A; Smolarz B; Fiks T; Kulig A
Pol J Pathol; 2007; 58(4):245-9. PubMed ID: 18459458
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
Zintzaras E
Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
[TBL] [Abstract][Full Text] [Related]
24. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
[TBL] [Abstract][Full Text] [Related]
25. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
Breast Cancer Res Treat; 2007 Jun; 103(2):209-17. PubMed ID: 17063276
[TBL] [Abstract][Full Text] [Related]
26. XPD common variants and their association with melanoma and breast cancer risk.
Debniak T; Scott RJ; Huzarski T; Byrski T; Masojć B; van de Wetering T; Serrano-Fernandez P; Górski B; Cybulski C; Gronwald J; Debniak B; Maleszka R; Kładny J; Bieniek A; Nagay L; Haus O; Grzybowska E; Wandzel P; Niepsuj S; Narod SA; Lubinski J
Breast Cancer Res Treat; 2006 Jul; 98(2):209-15. PubMed ID: 16685590
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
[TBL] [Abstract][Full Text] [Related]
28. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
29. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.
Manuguerra M; Saletta F; Karagas MR; Berwick M; Veglia F; Vineis P; Matullo G
Am J Epidemiol; 2006 Aug; 164(4):297-302. PubMed ID: 16707649
[TBL] [Abstract][Full Text] [Related]
30. Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression.
Wolfe KJ; Wickliffe JK; Hill CE; Paolini M; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Nov; 17(11):897-905. PubMed ID: 18075460
[TBL] [Abstract][Full Text] [Related]
31. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
32. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
33. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
34. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
Ye W; Kumar R; Bacova G; Lagergren J; Hemminki K; Nyrén O
Carcinogenesis; 2006 Sep; 27(9):1835-41. PubMed ID: 16571649
[TBL] [Abstract][Full Text] [Related]
35. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
37. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
38. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
39. Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects.
Niu W; Qi Y; Gao P; Zhu D
Breast Cancer Res Treat; 2010 Nov; 124(1):243-9. PubMed ID: 20232138
[TBL] [Abstract][Full Text] [Related]
40. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies.
Zhan P; Wang Q; Wei SZ; Wang J; Qian Q; Yu LK; Song Y
J Thorac Oncol; 2010 Sep; 5(9):1337-45. PubMed ID: 20651612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]